Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Nov;11(11):1569-78.
doi: 10.1586/ern.11.153.

The corticobasal syndrome-Alzheimer's disease conundrum

Anhar Hassan  1 , Jennifer L Whitwell, Keith A Josephs
Affiliations
Review

The corticobasal syndrome-Alzheimer's disease conundrum

Anhar Hassan et al. Expert Rev Neurother. 2011 Nov.

Abstract

Corticobasal syndrome (CBS), once thought to be pathognomonic for corticobasal degeneration pathology, is increasingly reported with various underlying pathologies. Alzheimer's disease is one such pathology, also once believed to be unique for its clinical syndrome of dementia of the Alzheimer's type. CBS is believed to result from topography of asymmetric parietofrontal cortical lesion involvement, rather than lesion subtype. However, this topographical pattern is strikingly different to that typically associated with AD for unclear reasons. This article will focus on CBS with underlying AD pathology (CBS-AD), and will review associated clinical, imaging and demographic factors. Predicting AD pathology is of marked interest as disease-modifying therapies loom on the horizon, with biomarkers and imaging research underway. By reviewing the literature for CBS-AD case reports and series and contrasting them with CBS with underlying corticobasal degeneration pathology cases, the article aims to examine factors that may predict AD pathology. How AD pathology may produce this clinical phenotype, rather than the prototype dementia of the Alzheimer's type, will also be reviewed.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Voxel-based morphometry results showing patterns of gray matter loss in six subjects with corticobasal syndrome with corticobasal degeneration and five subjects with corticobasal syndrome with Alzheimer’s disease compared with 20 age- and gender-matched controls
The CBS-AD subjects were more highly educated and younger than the CBS-CBD subjects. Age and gender were included as covariates in the model. Results are shown on transparent renders of the brain at a statistical threshold of p < 0.001 uncorrected for multiple comparisons. AD: Alzheimer’s disease; CBD: Corticobasal degeneration; CBS: Corticobasal syndrome; L: Left; R: Right.
See this image and copyright information in PMC

References

    1. Boeve BF. Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Dis Assoc Disord. 2007;21(4):S31–S38. - PubMed
    1. Hu WT, Rippon GW, Boeve BF, et al. Alzheimer’s disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord. 2009;24(9):1375–1379. Demonstrates that the presence of myoclonus suggests corticobasal syndrome with Alzheimer’s disease (CBS-AD) - PubMed
    1. Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH. Is the pathology of corticobasal syndrome predictable in life? Mov Disord. 2009;24(11):1593–1599. Details that the presence of memory impairment suggests CBS-AD. - PubMed
    1. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66(1):41–48. - PubMed
    1. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology. 1997;48(4):959–969. - PubMed

Publication types